Aggressive locoregional behavior of cutaneous squamous cell carcinoma during ruxolitinib use

Ann Dermatol Venereol. 2021 Jun;148(2):140-141. doi: 10.1016/j.annder.2020.10.018. Epub 2021 Jan 19.
No abstract available

Keywords: Cutaneous squamous cell carcinoma; JAK inhibitors; Prognosis; Ruxolitinib.

Publication types

  • Letter

MeSH terms

  • Carcinoma, Squamous Cell* / drug therapy
  • Humans
  • Nitriles
  • Pyrazoles / adverse effects
  • Pyrimidines
  • Signal Transduction
  • Skin Neoplasms* / drug therapy

Substances

  • Nitriles
  • Pyrazoles
  • Pyrimidines
  • ruxolitinib